Panchkula: Haryana health minister Kumari Arti Singh Rao has ordered the food and drug administration (FDA) department to ...

Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...

A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.

DUBLIN--(BUSINESS WIRE)--The "Orphan Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Orphan Drugs was estimated at US$ ...

By every measure, that spending is on the rise; by drug “list price,” the increase is astronomical—from $636 billion in 2018 to $917 billion in 2023. What exactly are PBMs saving us from ...

Stimulant medications are considered the first-line treatment for ADHD for some very good reasons. Here are 6 things to know about stimulant medications in ADHD. Attention Deficit Hyperactivity ...

Most people don't need any kind of treatment for mild cold symptoms. But if you do take cold medications, always check the label for side effects and carefully follow the instructions for use.

China’s healthcare regulator has pledged to investigate the quality of drugs under a new list covered by national insurance, after policy advisers in Shanghai warned that they might be substandard.